Parimifasor

Parimifasor (LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD) .

Product Specifications

CAS Number

1796641-10-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

460.214

Molecular Formula

C18H11Cl2F4N5O

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MR214558L3 10 µg

Olfr175 (Olfr175-ps1) (NM_147002) Mouse Tagged Lenti ORF Clone

Ask

View Details

NB110-61002JF646 0.1 mL

Mouse Monoclonal TIMP-3 Antibody (MM0036-7D3) [Janelia Fluor 646]

Ask

View Details

TA377134 100 µL

HMGB2 Rabbit Polyclonal Antibody

Ask

View Details

GTR15175534 1 Vial

Lentiviral mouse Nkx6-3 shRNA (UAS) - Lentiviral mouse Nkx6-3 shRNA (UAS, GFP) plasmid

Ask

View Details

RC229002L3 10 µg

SETDB2 (NM_001160308) Human Tagged Lenti ORF Clone

Ask

View Details

MBS2127789-01 0.1 mL

APC_Cy7 Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask

View Details